I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Is circulating tumor cell count-driven cost-effective for f..:
Lin, Huiting
;
Wu, Wenhua
;
Lou, Xiaoya
...
The Breast. 74 (2024) - p. 103680 , 2024
Link:
https://doi.org/10.1016/j.breast.2024.103680
RT Journal T1
Is circulating tumor cell count-driven cost-effective for first-line therapy choice in HR+/HER2- metastatic breast cancer in the United States?
UL https://suche.suub.uni-bremen.de/peid=cr-10.1016_j.breast.2024.103680&Exemplar=1&LAN=DE A1 Lin, Huiting A1 Wu, Wenhua A1 Lou, Xiaoya A1 Wang, Yiming A1 Sun, Hong A1 Cai, Jiaqin A1 Liu, Suyan A1 Wei, Xiaoxia PB Elsevier BV YR 2024 SN 0960-9776 JF The Breast VO 74 SP 103680 LK http://dx.doi.org/https://doi.org/10.1016/j.breast.2024.103680 DO https://doi.org/10.1016/j.breast.2024.103680 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)